Conclusion. SLO is the most favorable osteotomy method for reducing displacement of the proximal segment in mandibular prognathism with asymmetry. (Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;110:18-24)”
“BACKGROUND: Our management of patients with idiopathic pulmonary arterial hypertension (iPAH) awaiting lung LY3023414 transplantation changed in 2006 with the introduction of extracorporeal life support (ECLS) as an option to bridge these patients to transplantation (BTT).

METHODS: To study the effect of this change on waiting

list mortality and post-transplant outcome, 21 consecutive iPAH patients listed for lung transplantation between January 2006 and September 2010 (second cohort) were compared with 23 consecutive iPAH patients listed between January 1997 and December 2005 (first cohort).

RESULTS: Between the first and second cohort, the number of patients admitted to

the hospital as BTT increased from 4% (1 of 23) to 48% (10 of 21; p = 0.0009). Six patients were BTT with ECLS in the second cohort, including 4 with the Nova lung device (Nova lung GmbH, Hechingen, Germany) connected as a pumpless oxygenating right-to-left shunt between the pulmonary artery and left atrium. While on the waiting list, 5 patients (22%) died in the first cohort and none in the second cohort (p = 0.03). Time on the waiting list decreased from 118 +/- 85 to 53 +/- 40 days between the first and second cohort (p = 0.004). After lung transplantation, the 30-day mortality was 16.7% in the P005091 Ubiquitin inhibitor first cohort and 9.5% in the second cohort (p = 0.5). The postoperative intensive Selleck Birinapant care unit stay increased from 17 +/- 13 to 36 +/- 30 days between the first and second cohort (p = 0.02). The long-term outcome after lung transplantation

remained similar between both cohorts.

CONCLUSIONS: Aggressive management with ECLS of iPAH patients awaiting lung transplantation could have a major impact to reduce the waiting list mortality. This may, however, be associated with longer intensive care unit stay after transplant. J Heart Lung Transplant 2011;30:997-1002 (C) 2011 International Society for Heart and Lung Transplantation. All rights reserved.”
“The effect of hydrogenating process on the homogeneity of hydrogen absorption in the La0.8Ce0.2(Fe1-xMnx)(11.5)Si-1.5 compounds was investigated. It is attractive that the distribution of hydrogen atoms in the compounds becomes more uniform with increasing hydrogen pressure and annealing temperature. Homogeneous hydrides of La0.8Ce0.2(Fe0.985Mn0.015)(11.5)Si-1.5 were obtained by annealing them at the temperature of 773 K and under the hydrogen atmosphere of 0.5 MPa. With changes of Mn content, the Curie temperatures (T-C) of the hydrides of La0.8Ce0.2(Fe1-xMnx)(11.5)Si-1.5 can be adjusted in the room temperature range from 279 to 312 K.